Valuation: Seer, Inc.

Market Cap 119M 104M 96.21M 88.68M 167M 11.49B 171M 1.15B 452M 5.63B 448M 438M 19.37B P/E 2026 *
-2.08x
P/E 2027 * -2.21x
Enterprise Value 119M 104M 96.21M 88.68M 167M 11.49B 171M 1.15B 452M 5.63B 448M 438M 19.37B EV / Sales 2026 *
7.34x
EV / Sales 2027 * 5.69x
Free-Float
85.54%
Yield 2026 *
-
Yield 2027 * -
1 day+0.46%
Current month+30.72%
1 month+26.16%
3 months+8.50%
6 months+14.81%
Current year+18.58%
1 week 2.14
Extreme 2.14
2.19
1 month 1.55
Extreme 1.55
2.34
Current year 1.55
Extreme 1.55
2.34
1 year 1.55
Extreme 1.55
2.41
3 years 1.46
Extreme 1.455
5.65
5 years 1.46
Extreme 1.455
45.85
10 years 1.46
Extreme 1.455
86.55
Manager TitleAgeSince
Chief Executive Officer 57 2018-02-28
Director of Finance/CFO 58 2020-04-30
Chief Operating Officer - -
Director TitleAgeSince
Chairman 57 2020-08-31
Director/Board Member 76 2017-11-30
Director/Board Member 70 2017-11-30
Date Insider Type Main position Quantity % Market Cap.
7/8/26 Sell

Director

-10,660 0.0193%
5/20/26 Sell

Chief Financial Officer

-7,303 0.0129%
5/8/26 Free

Executive/Senior Manager

300,000 0.5317%
Change 5-day change 1-year change 3-year change Capi.($)
+0.46%0.00%+2.36%-55.98% 119M
-1.88%+1.07%+8.65%-1.39% 26.98B
-0.55%+0.97%+24.22%-3.17% 7.48B
-14.97%-25.66%+60.64%+112.45% 4.15B
-1.32%-1.59%+11.32%-47.15% 2.83B
-7.23%+2.03%+87.62%+66.16% 2.6B
-15.16%-31.45%+107.35%+68.47% 2B
-7.97%-22.03%+8.14%+0.91% 1.68B
-3.19%-4.27%-12.54%+36.22% 1.21B
-3.17%-10.21%+93.37%+60.19% 943M
Average -5.50%-4.88%+39.11%+23.67% 5B
Weighted average by Cap. -3.80%-1.22%+24.55%+13.53%

Financials

2026 *2027 *
Net sales 16.25M 14.2M 13.1M 12.08M 22.77M 1.56B 23.27M 157M 61.61M 766M 61.03M 59.69M 2.64B 20.95M 18.31M 16.89M 15.57M 29.35M 2.02B 30M 202M 79.42M 988M 78.68M 76.95M 3.4B
Net income -58.65M -51.25M -47.3M -43.6M -82.17M -5.65B -83.99M -565M -222M -2.77B -220M -215M -9.52B -55.7M -48.68M -44.92M -41.4M -78.04M -5.36B -79.77M -537M -211M -2.63B -209M -205M -9.04B
Net Debt - -
Logo Seer, Inc.
Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.
Employees
124
Date Price Change Volume
26-07-17 US$2.170 +0.46% 121,371
26-07-16 US$2.160 0.00% 202,167
26-07-15 US$2.160 0.00% 310,397
26-07-14 US$2.160 -0.46% 142,655
26-07-13 US$2.170 0.00% 365,132
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.170USD
Average target price
4.000USD
Spread / Average Target
+84.33%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SEER Stock